Federal Register / Vol. 72, No. 246 / Wednesday, December 26, 2007 / Notices 73027 

children and families and repeating the 

data collection procedures used in the 

original study. Selection of a new cohort 

will allow the comparison of 

characteristics of children who are 

entering the child welfare system today 

with those who entered prior to the 

implementation of the Adoption and 

Safe Families Act and prior to the 

advent of the Child and Family Services 

Review process. The data collection will 

follow the same format as that used in 

previous rounds of data collection, and 

will employ, with only modest 

revisions, the same instruments that 

have been used in previous rounds. 

Currently, HHS intends to collect 

baseline data and one follow-up 18 

months later, with future follow-up 

rounds contingent on funding 

availability. Data from NSCAW are 

made available to the research 

community though licensing 

arrangements from the National Data 

Archive on Child Abuse and Neglect at 

Cornell University. 

Respondents: 5,700 children and their 

associated permanent or foster 

caregivers, caseworkers, and teachers; in 

addition, an administrator will be 

interviewed in each location from 

which children are sampled. 

ANNUAL BURDEN ESTIMATES

Instrument Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden hours 

per response 

Total burden 

hours 

Child Interview ............................................................................................... 5,700 1 1 .2 6,840 

Permanent Caregiver Interview ..................................................................... 3,800 1 2 .0 7,600 

Foster Caregiver Interview ............................................................................ 1,990 1 1 .5 2,985 

Caseworker Interview .................................................................................... 5,700 1 1 .0 5,700 

Teacher Questionnaire .................................................................................. 3,000 1 .75 2,250 

Agency Questionnaire ................................................................................... 97 1 1 .0 97 

Estimated Total Annual Burden Hours: .................................................. ........................ ........................ .......................... 25,472 

Additional Information 

Copies of the proposed collection may 

be obtained by writing to the 

Administration for Children and 

Families, Office of Administration, 

Office of Information Services, 370 

L’Enfant Promenade, SW., Washington, 

DC 20447, Attn: ACF Reports Clearance 

Officer. All requests should be 

identified by the title of the information 

collection. E-mail address: 

infocollection@acf.hhs.gov. 

OMB Comment 

OMB is required to make a decision 

concerning the collection of information 

between 30 and 60 days after 

publication of this document in the 

Federal Register. Therefore, a comment 

is best assured of having its full effect 

if OMB receives it within 30 days of 

publication. Written comments and 

recommendations for the proposed 

information collection should be sent 

directly to the following: Office of 

Management and Budget, Paperwork 

Reduction Project, FAX: 202–395–6974, 

Attn: Desk Officer for ACF. 

Dated: December 17, 2007. 

Brendan Kelly, 

Reports Clearance Officer. 

[FR Doc. 07–6143 Filed 12–21–07; 8:45 am] 

BILLING CODE 4184–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Submission for OMB Review; 

Comment Request 

Title: Compassion Capital Fund 

Impact Evaluation Process Study. 

OMB No.: New Collection. 

Description: The information 

collection activity proposed under this 

notice will obtain information about 

intermediary grantee agencies providing 

capacity building assistance to faithbased and community organizations 

under the Compassion Capital Fund 

(CCF) Demonstration program. The 

information gathered under this data 

collection activity will be used to 

describe the approach and methods 

used by intermediaries to provide the 

services that are being evaluated in the 

CCF impact evaluation. Information 

collection will be through informal 

discussions and observations on-site at 

the organizations, using uniform 

protocols. 

Respondents: Directors and staff 

providing technical assistance and 

related services to faith-based and 

community organizations and directors 

and staff in faith-based and community 

organizations that have received 

capacity building assistance. 

ANNUAL BURDEN ESTIMATES

Instrument Number of 

respondents 

Number of 

responses 

per 

respondent 

Average 

burden 

hours per 

response 

Total 

burden hours 

Intermediary Protocol for Executive Director ................................................... 10 1 3 30 

Intermediary Protocol for Key Staff ................................................................. 30 1 1 30 

Faith-based or Community Organization Protocol for Executive Director ...... 30 1 2 60 

Faith-based or Community Organization Protocol for Key Staff ..................... 60 1 1 60 

Estimated Total Annual Burden 

Hours: 180. 

Additional Information: 

Copies of the proposed collection may 

be obtained by writing to the 

Administration for Children and 

Families, Office of Administration, 

Office of Information Services, 370 

L’Enfant Promenade, SW., Washington, 

DC 20447, Attn: ACF Reports Clearance 

Officer. All requests should be 


pwalker on PROD1PC71 with NOTICES
73028 Federal Register / Vol. 72, No. 246 / Wednesday, December 26, 2007 / Notices 

identified by the title of the information 

collection. E-mail address: 

infocollection@acf.hhs.gov. 

OMB Comment: 

OMB is required to make a decision 

concerning the collection of information 

between 30 and 60 days after 

publication of this document in the 

Federal Register. Therefore, a comment 

is best assured of having its full effect 

if OMB receives it within 30 days of 

publication. Written comments and 

recommendations for the proposed 

information collection should be sent 

directly to the following: Office of 

Management and Budget, Paperwork 

Reduction Project, Fax: 202–395–6974, 

Attn: Desk Officer for ACF. 

Dated: December 18, 2007. 

Brendan Kelly, 

Reports Clearance Officer. 

[FR Doc. 07–6158 Filed 12–21–07; 8:45 am] 

BILLING CODE 4184–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. 2007N–0472] 

Agency Emergency Processing Under 

the Office of Management and Budget 

Review; Certification to Accompany 

Drug, Biological Product, and Device 

Applications or Submissions; 

Correction 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice; correction. 

SUMMARY: The Food and Drug 

Administration (FDA) is correcting a 

notice that appeared in the Federal 

Register of December 12, 2007 (72 FR 

70599). The document announced that a 

proposed collection of information had 

been submitted to the Office of 

Management and Budget (OMB) for 

emergency processing under the 

Paperwork Reduction Act of 1995. The 

document was published with an error. 

This document corrects that error. 

FOR FURTHER INFORMATION CONTACT: 

Joyce Strong, Office of Policy, Planning, 

and Preparedness (HF–27), Food and 

Drug Administration, 5600 Fishers 

Lane, Rockville, MD 20857, 301–827–

7010. 

SUPPLEMENTARY INFORMATION:IN FR DOC. 

07–6023, APPEARING ON PAGE 70599 IN THE

Federal Register OF WEDNESDAY, 

DECEMBER 12, 2007, THE FOLLOWING

CORRECTION IS MADE: 1. On page 70599, in 

the third column, in the second full 

paragraph, the second sentence is 

corrected to read ‘‘Specifically, at the 

time of submission of an application 

under sections 505, 515, or 520(m) of 

the FD&C Act (21 U.S.C. 355, 360e, or 

360j(m)), or under section 351 of the 

PHS Act (42 U.S.C. 262), or submission 

of a report under section 510(k) of the 

FD&C Act (21 U.S.C. 360(k)), such 

application or submission must be 

accompanied by a certification that all 

applicable requirements of section 

402(j) of the PHS Act have been met.’’

Dated: December 17, 2007. 

Jeffrey Shuren, 

Assistant Commissioner for Policy. 

[FR Doc. E7–24914 Filed 12–21–07; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. 2007C–0474] 

DSM Nutritional Products, Inc.; Filing 

of Color Additive Petition; Correction 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice; correction. 

SUMMARY: The Food and Drug 

Administration is correcting a notice 

that appeared in the Federal Register of 

December 4, 2007 (72 FR 68166). The 

document announced that DSM 

Nutritional Products, Inc., has filed a 

petition proposing that the color 

additive regulations be amended to 

provide for the safe use of astaxanthin 

dimethyldisuccinate as a color additive 

in the feed of salmonid fish to enhance 

the color of their flesh. 

FOR FURTHER INFORMATION CONTACT: 

Joyce Strong, Office of Policy, Planning, 

and Preparedness, Food and Drug 

Administration, 5600 Fishers Lane, 

Rockville, MD 20857, 301–827–7010. 

SUPPLEMENTARY INFORMATION: In FR Doc. 

E7–23473, appearing on page 68166 in 

the Federal Register of Tuesday, 

December 4, 2007, the following 

correction is made: 

1. On page 68166, in the third 

column, in the heading of the 

document, ‘‘[Docket No. 2007N–0453]’’

is corrected to read ‘‘[Docket No. 

2007C–0474]’’. 

Dated: December 17, 2007. 

Laura M. Tarantino, 

Director, Office of Food Additive Safety, 

Center for Food Safety and Applied Nutrition. 

[FR Doc. E7–24911 Filed 12–21–07; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

Clinical Trial Design for CommunityAcquired Pneumonia; Public 

Workshop 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice of public workshop. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing a 

public workshop, cosponsored with the 

Infectious Diseases Society of America 

(IDSA), regarding scientific issues in 

clinical trial design for communityacquired pneumonia. This public 

workshop is intended to provide 

information for and to gain perspective 

from health care providers, academia, 

and industry on various aspects of 

antimicrobial drug development for 

community-acquired pneumonia, 

including diagnosis of communityacquired pneumonia, effect of 

antimicrobial treatment for communityacquired pneumonia, endpoints for 

trials of community-acquired 

pneumonia, and statistical issues in 

analysis of results of trials in 

community-acquired pneumonia. The 

input from this public workshop will 

help in developing topics for further 

discussion. 

Date and Time: The public workshop 

will be held on January 17, 2008, from 

8 a.m. to 6 p.m. and on January 18, 

2008, from 8 a.m. to 5 p.m. 

Location: The public workshop will 

be held at the Crowne Plaza Hotel, 

Kennedy Room, 8777 Georgia Ave., 

Silver Spring, MD 20910, 301–589–

0800. Seating is limited and available 

only on a first-come, first-served basis. 

Contact Person: Chris Moser or Lori 

Benner, Center for Drug Evaluation and 

Research, Office of Antimicrobial 

Products, Food and Drug 

Administration, 10903 New Hampshire 

Ave., Bldg. 22, rm. 6413, Silver Spring, 

MD 20993–0002, 301–796–0767, or 

301–796–0849. 

Registration: There is no registration 

fee for the public workshop. Space is 

limited; therefore, interested parties are 

encouraged to register early. Seating 

will be available on a first-come, firstserved basis. To register electronically, 

e-mail registration information 

(including name, title, firm name, 

address, telephone, and fax number) to 

CAPwkshp@fda.hhs.gov by January 9, 

2008. Persons without access to the 

Internet can call 301–796–1300 to 

register. Persons needing a sign 

language interpreter or other special 


pwalker on PROD1PC71 with NOTICES